CHDR Annual Report 2022
Contents 2022
  • Homepage
  • 2022 in perspective
  • Developing drugs
  • Developing methods
  • Developing people
  • 2022 stories
Other years

Developing methods

Developing precise, data-rich methods for early clinical drug research is one of the unique aspects of CHDR’s work. 2022 saw new developments in methods for neurology, immunology, dermatology, oncology, and more.

Deep phenotyping mycosis fungoides: profiling an orphan malignancy

Developing biomarkers to study drugs for neurodegenerative diseases

Laying the foundations for faster vaccine development

The search for human complement challenge models

Assessing the pharmacokinetics of large molecules in the CNS

Bone marrow puncture procedure opens up new opportunities for early phase immuno-oncology trials

Developing and validating a finger tapping test for Parkinson’s disease

Back to homepage
  • © CHDR 2026
  • +31 (0)71 5246400
  • info@chdr.nl
  • www.chdr.nl
  • Download report as PDF

Text

Pieter van Megchelen

Editing

Echt English

Photography and video

Michiel Plas, Maarten Slooves, Samantha Prins

Design

JUST — wearejust.com